Suprima II Model 254-26
by Intermedics, Inc. 510(k)
Active
510(k) K852431
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK852431 | Date19 Jul 1985 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Suprema II Model 254-26 is an implantable pacemaker pulse-generator, designed to regulate cardiac rhythm by delivering electrical impulses to the heart. This device is classified as a Class III medical device under FDA regulations, intended for patients requiring artificial cardiac pacing to manage bradycardia or other conduction disorders.
This pulse-generator is supplied sterile and intended for single-use implantation by qualified healthcare professionals in a clinical setting. It is regulated under FDA 510(k) clearance (K852431) and adheres to the specifications outlined in regulation number 870.3610. The device is not MRI-safe and must be handled with care to ensure proper functionality and patient safety.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What clinical condition is this device intended to address, and how does it work?
The Suprema II Model 254-26 is designed to address bradycardia or conduction disorders by regulating cardiac rhythm. It functions as an implantable pacemaker pulse-generator, delivering controlled electrical impulses to the heart to maintain a proper heartbeat when the natural conduction system fails.
Is this device intended for reuse, or is it meant to be implanted as a single-use device?
This device is explicitly intended for single-use implantation. It is supplied sterile and must be implanted by qualified healthcare professionals in a clinical setting, ensuring patient safety and proper functionality.
What regulatory pathway was followed for this device’s clearance, and which committee reviewed it?
The Suprema II Model 254-26 followed the FDA’s 510(k) clearance pathway, specifically under the traditional review process. It was classified as substantially equivalent (SESE) and reviewed by the Cardiovascular (CV) Advisory Committee.
Can this device be used in patients who require MRI procedures, or are there specific safety concerns?
This device is explicitly not MRI-safe. It must be handled with care, and MRI procedures should be avoided to prevent interference with its functionality or potential harm to the patient.
How is the device supplied, and what precautions should be taken during handling?
The device is supplied sterile and intended for direct implantation by trained professionals. Since it is single-use, proper sterile techniques must be followed during handling to prevent contamination and ensure safe implantation.